Scientific Advisors

Kidney cancer research is a fast-moving space. The following Advisory Board members provide guidance and ensure we stay up-to-date.

“Kidney cancer is the ideal sandbox for new approaches, and without a doubt these approaches can, should, and will be suitable for other cancers.”

Dr. Hans Hammers

Mehmet Bilen, MD

Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine.
Director, Genitourinary Medical Oncology Program, Winship Cancer Institute of Emory University.
Associate Medical Director, Phase I Unit,
Winship Cancer Institute of Emory University

Gennady Bratslavsky, MD

Professor and Chair of Urology Professor of Biochemistry and Molecular Biology Division Chief of Upstate Urology at 550 Harrison Division Chief of Urologic Male Health Director of Prostate Cancer Program Department Chief of Adult Urology Clinic Department Chief of Urologic Oncology

James Brugarolas, MD, PhD

Professor of Internal Medicine, Cancer Biology, Genetics, Development and Disease. The founding Director of the Kidney Cancer Program at UT Southwestern Simmons Cancer Center and Principal Investigator of one of two Specialized Programs of Research Excellence (SPORE) in kidney cancer in the U.S.

Toni Choueiri, MD

Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Women’s Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.

Rachel Giles, MD

Staff, Internal Medicine Dept. Nephrology and Hypertension
University Medical Center Utrecht, The Netherlands
Chair – IKCC Board

Hans Hammers, MD, PHD

Associate Professor of Internal Medicine in the Division of Hematology-Oncology at UT Southwestern Medical Center. Co-leader of clinical research of the Kidney Cancer Program at Simmons Cancer Center.

Eric Jonasch, MD

Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Payal Kapur, MD

Dr. Kapur is on faculty in the Department of Pathology and Urology at UT Southwestern and the Group Leader of Genitourinary Pathology and the Co-Leader of the Kidney Cancer Program at Simmons Cancer Center.

Marc Michaelson, MD, PhD

Director, Massachusetts General Hospital Hematology/Oncology Fellowship Program

Mehdi Mollapour, PhD

Professor, Vice Chair for Translational Research and Director of Renal Cancer Biology Program for the Department of Urology. Adjunct Professor at the Department of Biochemistry and Molecular Biology at SUNY Upstate Medical University.

Eric Singer, MD, MA, FACS

Associate Chief of Urology
Director, Kidney Cancer Program
Rutgers Cancer Institute of New Jersey
Associate Professor of Surgery and Radiology

Ramaprasad Srinivasan, MD, PHD

Investigator Urologic Oncology Branch Head, Molecular Cancer Therapeutics Section NCI
KCRS22 October 6-7, 2022

 KCRS is an annual meeting focused on basic, translational, and clinical kidney cancer research. The meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.

The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.

KCRS22 WILL BE HELD ON OCTOBER 6-7, 2022

For Patients

Advocacy

Research

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Deb Beyhan is the Patient Legislative Advocate for KidneyCAN. She was diagnosed with stage IV kidney cancer in 2016 at the age of 53. Deb lives outside of Atlanta, GA, with her husband.    For this month's Community Spotlight, we want to tell you about a member of our volunteer team, Deb Beyhan....

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

District Days: Asking Congress to Fund Kidney Cancer Research

District Days: Asking Congress to Fund Kidney Cancer Research

On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

The 2022 Kidney Cancer Research Summit

The 2022 Kidney Cancer Research Summit

Dr. Laurence Albiges (Institut Gustave Roussy) presents on the microbiome at KCRS22. The microbiome has now been recognized as one of the emerging hallmarks and enabling characteristics of cancer. KidneyCAN hosted the 4th Annual Kidney Cancer Research Summit on October 6-7, 2022  live in...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Rock the Run for Kidney Cancer Research Funding

Rock the Run for Kidney Cancer Research Funding

KidneyCAN had the first ever Rock the Run 5k fundraiser in October 2022. This is part of the group of KCRS22 attendees who walked and ran with us at dawn before the second conference day began. KidneyCAN is proud to share the results of the first annual Rock the Run 5K fundraiser. Our Purpose...